Dr. Michael Beeton is a Reader in Medical Microbiology with over 15 years of experience researching mycoplasmas and ureaplasmas and their implications for human health. From 2019 to 2021 he was the Science Officer for the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study
Group for Mycoplasma and Chlamydia Infections (ESGMAC) and then took on the role of Chair of the ESGMAC from 2021 – 2023.
His previous research has aimed to understand the prevalence and mechanisms of antibiotic resistance among mycoplasmas and ureaplasmas of the urogenital tract. He has expanded his research to respiratory mycoplasmas, shedding light on the impact of Mycoplasma pneumoniae on respiratory infections. Additionally, he is investigating the prevalence and antibiotic resistance of the emerging pathogen Mycoplasma amphoriforme. More recently Dr Beeton has co-led the first prospective global surveillance study for M. pneumoniae, the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study. This study identified where and when M. pneumoniae returned after its absence following the implementation of non-pharmaceutical interventions in response to the COVID-19 pandemic. He is currently leading a research project to improve molecular surveillance of M. pneumoniae across Europe and beyond. Dr. Beeton’s dedication to advancing medical microbiology highlights his interdisciplinary approach and collaborative efforts. His focus on addressing critical infectious disease issues emphasizes unraveling microbial pathogen complexities.
